UDG Healthcare

Last updated

UDG Healthcare plc
IndustryPharmaceutical
Founded1948 (1948)
Headquarters Dublin, Ireland
Key people
Peter Gray, Chairman
Brendan McAtamney, CEO [1]
RevenueDecrease2.svg 1,279.2 million (2020) [2]
Increase2.svg 130.9 million (2020) [2]
Increase2.svg 92.8 million (2020) [2]
Number of employees
9,000 (2021) [3]
Parent Clayton, Dubilier & Rice
Website www.udghealthcare.com

UDG Healthcare plc, formerly United Drug, is a Dublin-based international company and partner to the healthcare industry, providing clinical, commercial, communication and packaging services. It was listed on the London Stock Exchange until it was acquired by American private equity company Clayton, Dubilier & Rice in August 2021.

Contents

History

The company was established in Ballina in County Mayo as The United Drug Chemical Company, a co-operative controlled by Irish pharmacists, in 1948. [4] UDG bought Leicestershire-based Ashfield Healthcare for £16.5 million in 2000. [5]

In January 2007, the company acquired Presearch, a UK laboratory services company, for GBP £2.9 million. [6] It acquired Pharmexx, a Frankfurt-based business, in July 2012. [7] In September 2012 it decided to move its primary listing from Irish Stock Exchange to the London Stock Exchange. [8] It changed its name from United Drug to UDG Healthcare in October 2013. [9] In February 2014, the company made its largest acquisition when it bought KnowledgePoint360 which specializes in healthcare communications for €105 million and made it part of its Ashfield division. [10] [11]

In September 2015, UDG Healthcare sold its Irish drug distribution businesses to McKesson Corporation for $466 million. [12] In May 2016 UDG Healthcare acquired Pegasus, an integrated healthcare communications consultancy. [13] In October 2016 the company acquired STEM Marketing, a provider of commercial, marketing and medical audits to pharmaceutical companies. [14] In July 2017, the company acquired Vynamic; later in the same month it acquired Cambridge BioMarketing for up to $35 million. [15] In August 2018, UDG Healthcare announced the sale of its Aquilant division to H2 Equity Partners, a European private equity firm, for a total potential net consideration of up to €23 million (approximately $27 million). [16]

The company agreed to be acquired by Clayton, Dubilier & Rice in a £2.8 billion transaction in June 2021. [17]

Operations

UDG Healthcare plc operates across two divisions: Ashfield and Sharp. [18]

Related Research Articles

DCC plc is a leading Irish international sales, marketing and support services group. Headquartered in Dublin, the Group operates across three sectors: energy, healthcare and technology. DCC plc is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

McKesson Corporation is a publicly-traded American company that distributes pharmaceuticals and provides health information technology, medical supplies, and health management tools. The company delivers a third of all pharmaceuticals used in North America and employs over 51,000 employees. With $308.9 billion in 2024 revenue, it is the ninth-largest company by revenue in the United States and the nation's largest health care company. The company is headquartered in Irving, Texas. It is a member of the S&P 500 and New York Stock Exchange, where it is traded under the ticker symbol NYSE: MCK.

<span class="mw-page-title-main">Cardinal Health</span> American multinational health care services company

Cardinal Health, Inc. is an American multinational health care services company, and the 14th highest revenue generating company in the United States. Headquartered in Dublin, Ohio, the company specializes in the distribution of pharmaceuticals and medical products, serving more than 100,000 locations. The company also manufactures medical and surgical product, including gloves, surgical apparel, and fluid management products. In addition, it operates one of the largest networks of radiopharmacies in the U.S. Cardinal Health provides medical products to over 75 percent of hospitals in the United States.

Ferguson plc is an American-British multinational plumbing and heating products distributor with its head office in Newport News, Virginia.

<span class="mw-page-title-main">Perrigo</span> Irish tax-registered pharmaceutical

Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters in Grand Rapids, Michigan, within Michigan State University's Grand Rapids Innovation Park.

<span class="mw-page-title-main">Clayton, Dubilier & Rice</span> American private equity company

Clayton, Dubilier & Rice, LLC (CD&R) is an American private equity company. It is one of the oldest private equity investment firms in the world. Founded in 1978, CD&R has managed the investment of more than $30 billion in approximately 90 businesses, representing a broad range of industries with an aggregate transaction value in excess of $140 billion. Approximately half of CD&R's investments have involved corporate divestitures.

Parexel International is an American provider of biopharmaceutical services. It conducts clinical trials on behalf of its pharmaceutical clients to expedite the drug approval process. It is the second largest clinical research organization in the world and has helped develop approximately 95% of the 200 top-selling biopharmaceuticals on the market today. The company publishes the annual Parexel R&D Statistical Sourcebook and operates the Parexel-Academy.

<span class="mw-page-title-main">Teva Pharmaceuticals</span> Israeli pharmaceutical company

Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company. Teva specializes primarily in generic drugs, but other business interests include branded-drugs, active pharmaceutical ingredients (API's) and, to a lesser extent, contract manufacturing services and an out-licensing platform.

<span class="mw-page-title-main">Actavis</span> Global pharmaceutical company

Actavis Generics is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial presence across approximately 100 countries. The company has global headquarters in Dublin, Ireland and administrative headquarters in Parsippany-Troy Hills, New Jersey, United States.

Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system. While Endo's management, operations, and customers are almost exclusively U.S.–based, in 2013 Endo executed a corporate tax inversion to Ireland to avoid U.S. corporate taxes on their U.S. drug sales, and to avail of Ireland's corporate tax system.

IQVIA, formerly Quintiles and IMS Health, Inc., is an American Fortune 500 and S&P 500 multinational company serving the combined industries of health information technology and clinical research. IQVIA is a provider of biopharmaceutical development, professional consulting and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including investment strategy and management consulting services. It has a network of more than 88,000 employees in more than 100 countries and a market capitalization of US$49 billion as of August 2021. As of 2023, IQVIA was reported to be one of the world's largest contract research organizations (CRO).

Hikma Pharmaceuticals plc is a British multinational pharmaceutical company with headquarters in London, UK that manufactures non-branded generic and in-licensed pharmaceutical products. It was founded by Samih Darwazah in Amman, Jordan in 1978. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

Informa plc is a British publishing, business intelligence, and exhibitions group based in London, England. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.

<span class="mw-page-title-main">Dechra Pharmaceuticals</span> Pharmaceutical Company based in UK

Dechra Pharmaceuticals plc is a business involved in the development and marketing of veterinary products based in Northwich, England. It is listed on the London Stock Exchange until it was acquired by EQT AB in January 2024.

Real Chemistry, formerly known as W2O Group, is a global health innovation company that utilizes artificial intelligence (AI) for its healthcare services. Founded by Jim Weiss in 2001, Real Chemistry is an American company with global offices in Europe and Canada.

AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. It is ranked sixth on the list of largest biomedical companies by revenue. In 2023, the company's seat in Forbes Global 2000 was 74, and rank 89 on the 2024 list. The company's primary product is Humira (adalimumab), administered via injection. It is approved to treat autoimmune diseases including rheumatoid arthritis, Crohn's disease, plaque psoriasis, and ulcerative colitis.

Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States. One of the company's considerable products is the United States Food and Drug Administration (FDA) approved drug Xyrem, the sodium salt of the naturally occurring neurotransmitter γ-Hydroxybutyric acid (GHB). In 2017, net product sales of Xyrem were $1.187 billion, which represented 74% of the company's total net product sales. In 2019, Jazz was granted FDA-approval to market Sunosi with indications for treating excessive daytime sleepiness (EDS) in narcolepsy as well as obstructive sleep apnea (OSA). In 2022, it was announced that Axsome Therapeutics would be acquiring Sunosi from Jazz Pharmaceuticals.

Horizon Therapeutics was a biopharmaceutical company focused on researching, developing, and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Horizon primarily markets products in the United States, which represented 97% of Horizon's 2019 worldwide sales. Amgen acquired the company in October 2023.

<span class="mw-page-title-main">Advanz Pharma</span> British pharmaceutical company

Advanz Pharma Corp. is a British multinational pharmaceutical company headquartered in London. It changed its name from Concordia Healthcare Corp. in November 2018. The company focuses on a number of therapy areas including endocrinology, ophthalmology, urology, anti-infectives, pain management, central nervous system disorders, oncology, haematology, cardiology and intensive care medicine. The company also focuses on acquiring legacy pharmaceutical compounds which are usually off-patent. The operational headquarters is in London, UK, operations centre in Mumbai, India and regional hubs in Europe, Australia and Canada.

ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry. As of June 2023, ICON had approximately 41,160 employees in 108 locations spread across 53 countries.

References

  1. Michael Cogley (3 February 2016). "UDG boss Fitzgerald steps down from €2.5m-a-year role". Independent.ie. Retrieved 31 July 2016.
  2. 1 2 3 "Annual Report 2020" (PDF). UDG Healthcare. Retrieved 3 March 2021.
  3. "At a glance". UDG Healthcare. Retrieved 3 March 2021.
  4. "Interview: Brendan McAtamney – CEO, UDG Healthcare, Ireland". Pharma Boardroom. 17 February 2017. Retrieved 5 March 2020.
  5. "United Drug buys Ashfield Healthcare". The Irish Times. 9 May 2000. Retrieved 3 March 2021.
  6. "United Drug buy UK lab distributor for £2.9m". RTÉ News. 26 January 2007.
  7. United Drug snaps up Pharmexx Irish Times, 26 July 2012
  8. United Drug set to shift to LSE FT, 5 September 2012
  9. United Drug: Yes to name change Irish Examiner, 10 August 2013
  10. UPDATE 2-UDG raises earnings growth forecast, sees deal paying off, Reuters.com (14 May 2014)
  11. UDG Healthcare invests €105m to expand communications unit The Irish Times , 27 February 2014
  12. Roshni Menon (18 September 2015). "UDG Healthcare to sell two units to McKesson for $466 million". Reuters.com. Archived from the original on 1 February 2016. Retrieved 31 July 2016.
  13. "Healthcare Group UDG buys UK's second largest PR firm Pegasus for £16.8 million". 19 May 2016. Retrieved 28 April 2017.
  14. "UDG Healthcare acquires STEM Marketing for £84m". PM Live. 21 October 2016. Retrieved 28 April 2017.
  15. "Rare disease agency Cambridge Bio goes global with $35M buyout by Irish UDG - FiercePharma". www.FiercePharma.com. 26 July 2017. Retrieved 22 January 2018.
  16. "UDG Healthcare sells non-core Aquilant division and reviews Ashfield business". 8 August 2018. Retrieved 14 November 2018.
  17. "UDG Healthcare accepts higher £2.8bn takeover bid". The Independent. 29 June 2021. Retrieved 1 August 2021.
  18. "Sharp Packaging Services, a division of UDG Healthcare plc, announces capacity expansion in the US and UK". FT. 3 April 2017. Retrieved 28 April 2017.